Cardiovascular Diseases
Pipeline by Development Stage
Drug Modality Breakdown
On Market (10)
Approved therapies currently available
Competitive Landscape
29 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
Showing 15 of 50 trials with date data
Clinical Trials (50)
Total enrollment: 2,252,382 patients across 50 trials
Empagliflozin and Cardiac Remodelling in People Without Diabetes
Diabetes Remote Intervention to improVe Use of Evidence-based Medications
Cardiovascular Disease in HIV and Hepatitis C: Risk Outcomes After Hepatitis C Eradication
Are the "Cardiac Benefits" of Empagliflozin Independent of Its Hypoglycemic Activity? (ATRU-4).
CRUSHed vs. Uncrushed Prasugrel in STEMI Patients Undergoing PCI
(MitraClip in Non-Responders to Cardiac Resynchronization Therapy)
Effect of Estradiol+Drospirenone Versus Estradiol+MPA on Endothelial Function
Efficacy of Ezetimibe/Simvastatin 10/20 mg and MK0524A (1-2 g/Day) in Mixed Hyperlipidemia and Two or More Risk Factors
Aspirin Dose and Atherosclerosis in Patients With Heart Disease
Aspirin Dose and Atherosclerosis in Patients With Metabolic Syndrome
PreFER Managed Ventricular Pacing (MVP) For Elective Replacement
Effectiveness and Safety of Ramipril Alone Compared With Telmisartan Alone and in Combination With Ramipril in Patients at High Risk for Cardiovascular Events. Patients Intolerant to Ramipril Were Entered in TRANSCEND, Telmisartan Compared to Placebo.
Study of Niacin and Rosiglitazone in Dysmetabolic Dyslipidemia
POISE Trial: Perioperative Ischemic Evaluation Study
Raloxifene Use for The Heart
Evaluate SLN360 in Participants With Elevated Lipoprotein(a) at High Risk of Atherosclerotic Cardiovascular Disease Events
Safety and Efficacy of Therapeutic Anticoagulation on Clinical Outcomes in Hospitalized Patients With COVID-19
A Series of Pilot Studies to Evaluate the haemoDynamic and mEtabolic Effects oF apelIn aNd rElaxin
Effects of NT-0796 in Obese Participants at Risk of Cardiovascular Disease
Treating Congestive HF With hiPSC-CMs Through Endocardial Injection
Ertugliflozin: Cardioprotective Effects on Epicardial Fat
Absorption, Distribution, Metabolism and Excretion of [14C] Labelled BIA 5-1058
Pharmacokinetics of Dabigatran Etexilate (Pradaxa®) During Haemodialysis
Pivotal Study for the Cardiac Performance System (CPS)
BEhavioral and Adherence Model for Improving Quality, Health Outcomes and Cost-Effectiveness of healthcaRe
Multi-Center Study of Clinical and Inflammatory Outcomes in Intensive Cardiac Rehabilitation and Traditional Cardiac Rehabilitation Programs
GISE Registry of Transcatheter Treatment of Mitral Valve Regurgitation With the MitraClip G4
Guideline Oriented Approach To Lipid Lowering In Asia-Pacific
Real World Evidence Study of Statin Use in Brazil
The Healthcare Evaluation of Absolute Risk Testing Study
Optimising Secondary Prevention and Quality of Life in Early Cardiac Rehabilitation
Melatonin and Risk Of Cardiovascular Events And Malignant Tumors In The Elderly
A Digital Flu Intervention for People With Cardiovascular Conditions
MitraClip EXPAND G4 Study
The Impact of Conventional Hemodialysis and Renal Transplantation on the Global Longitudinal Strain of the Left Ventricle
Management of Device Detected AT and Impact of Device Treatment Algorithms on Atrial Fibrillation
Transcatheter Mitral Valve Repair for the Treatment of Mitral Valve Regurgitation In Heart Failure (The EVOLVE-MR Trial)
Cardiometabolic Benefits of Potatoes Mediated Along the Gut-Vessel Axis in Adults With Metabolic Syndrome
Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Transcatheter Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation
Noninferiority Trial of MitraClip Implantation Strategies: 1 Clip vs. 2 Clips in Patients With Functional Mitral Regurgitation
MitraClip NT System Post-marketing Surveillance Study - Japan
Profiling Implantable Cardiac Device Diagnostics Trends During Clinical Events .
MitraClip in Acute Mitral Regurgitation
Brazilian inteRvention to Increase eviDence usaGe in practicE - Cardiovascular Prevention
The Role of Glucagon in the Effects of Dipeptidyl Peptidase-4 Inhibitors and Sodium-glucose Co-transporter-2 Inhibitors
Vascular Reactivity Assessment by the AngioDefender Device -- A Precision Study
Healthy Hearts in the Heartland
AngioDefender Versus Brachial Artery Ultrasound Imaging